Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 80Sarcoma 30Dermatologic 2Genitourinary 1Breast 1

Conditions

Breast Neoplasms 54Triple Negative Breast Neoplasms 8Carcinoma, Intraductal, Noninfiltrating 6Breast Neoplasms, Male 4Melanoma 3Inflammatory Breast Neoplasms 3Breast Carcinoma In Situ 3Brain Neoplasms 3Sarcoma 2Prostatic Neoplasms 2Lung Neoplasms 2Carcinoma, Merkel Cell 2Carcinoma, Ductal, Breast 2Bone Neoplasms 2To Evaluate the Safety of Taurine in Preventing Acute Radiation Skin Injury Induced by Adjuvant Radiotherapy in Breast Cancer Patients 1Squamous Cell Carcinoma of Head and Neck 1Pain 1Osteosarcoma 1Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Meningeal Carcinomatosis 1Lymphoma, Non-Hodgkin 1Lymphoma 1Glioblastoma 1Fatigue 1Estrogen Receptor Positive 1Deception 1Cardiotoxicity 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 3fludarabine 2Paclitaxel 2Gemcitabine 2Cyclophosphamide 2Azacitidine 2vocimagene amiretrorepvec 1temsirolimus 1spartalizumab 1sonidegib 1sacituzumab govitecan 1ruxolitinib 1rucaparib 1ridaforolimus 1pazopanib 1motexafin gadolinium 1lenvatinib 1durvalumab 1depatuxizumab mafodotin 1cediranib 1cc-486 1carboxyamido-triazole 1abiraterone 1Thalidomide 1Temozolomide 1Sorafenib 1Sirolimus 1Radiation 1Quality of Life 1Proton Pump Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioblastoma × Radiation × Breast × Clear all
NCT04478279 2026-02-09

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

Sapience Therapeutics

Phase 1/2 Active not recruiting
125 enrolled
BreastCNSDermatologicGenitourinary

Brain Neoplasms, Breast Neoplasms, Glioblastoma, Melanoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡